SMS Pharmaceuticals is currently trading at Rs. 31.35, up by 1.35 points or 4.50% from its previous closing of Rs. 30.00 on the BSE.
The scrip opened at Rs. 28.30 and has touched a high and low of Rs. 31.95 and Rs. 28.10 respectively. So far 899 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 1 has touched a 52 week high of Rs. 67.50 on 01-Apr-2019 and a 52 week low of Rs. 23.55 on 13-Mar-2020.
Last one week high and low of the scrip stood at Rs. 41.75 and Rs. 23.55 respectively. The current market cap of the company is Rs. 264.11 crore.
The promoters holding in the company stood at 67.29%, while Institutions and Non-Institutions held 0.55% and 32.16% respectively.
SMS Pharmaceuticals has received Establishment Inspection Report (EIR) from United States Food and Drug Administration (USFDA) for its API facility situated at Kandivalasa, Andhra Pradesh. The USFDA had inspected the said facility during the period January 13, 2020 to January 17, 2020. This facility predominantly caters regulated markets including USA.
SMS Pharmaceuticals is a global player in API manufacturing having strong research and manufacturing team supported by state of art facilities.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1525.00 |
Dr. Reddys Lab | 5942.65 |
Cipla | 1345.35 |
Zydus Lifesciences | 925.95 |
Lupin | 1547.05 |
View more.. |